Abstract
Patients treated with monoclonal antibodies directed against immunological molecules may be viewed as being similar to patients with primary immunodeficiency (PID) of the corresponding antibody target, with regards to infectious risk. László Maródi and Jean-Laurent Casanova propose that the natural history of PIDs might indicate which infectious diseases should be monitored in patients receiving therapeutic antibodies.
References
Wallis, R. S. Curr. Opin. Infect. Dis. 22, 403–409 (2009).
Martin-Mola, E. & Balsa, A. Rheum. Dis. Clin. N. Am. 35, 183–199 (2009).
Desai, S. B. & Furst, D. E. Best Pract. Res. Clin. Rheumatol. 20, 757–790 (2006).
Carson, K. R. et al. N. Engl. J. Med. 361, 816–824 (2009).
Quartier, P. et al. Clin. Infect. Dis. 36, e47–e49 (2003).
Aksoy, S. et al. Leuk. Lymphoma 50, 357–365 (2009).
Casanova, J.-L. & Abel, L. Science 317, 617–619 (2007).
Maródi, L. & Notarangelo, L. D. Nature Rev. Immunol. 11, 851–861 (2007).
Suzuki, T. et al. J. Exp. Med. 205, 2703–2710 (2008).
Martinez-Moczygemba, M. et al. J. Exp. Med. 205, 2711–2716 (2008).
Patel, S. Y. et al. J. Immunol. 175, 4769–4776 (2005).
Kampmann, B. et al. J. Clin. Invest. 115, 2480–2488 (2005).
Ram, R. et al. Leuk. Lymphoma 50, 1083–1095 (2009).
Kimby, E. Cancer Treat. Rev. 31, 456–473 (2005).
Kanbayashi, Y. et al. Eur. J. Haematol. 82, 26–30 (2009).
Kiani-Alikhan, S. et al. Br. J. Haematol. 146, 333–335 (2009).
Padate, B. P. & Keidan, J. Clin. Lab. Haematol. 28, 69–71 (2006).
Carrasco, R. et al. Paediatr. Drugs 6, 137–146 (2004).
Bustamante, J. et al. Curr. Opin. Immunol. 20, 39–48 (2008).
Zhang, S. Y. et al. Immunol. Rev. 226, 29–40 (2008).
Picard, C. et al. The clinical features and outcome of IRAK-4 and MyD88 deficiencies. Medicine (in the press).
Major, E. O. N. Engl. J. Med. 361, 1041–1043 (2009).
Maródi, L. & Casanova, J.-L. Lancet 373, 2179–2181 (2009).
Tóth, B. et al. Mol. Immunol. 46, 2140–2146 (2009).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Maródi, L., Casanova, JL. Can primary immunodeficiencies help to provide insights into infectious risks of therapeutic antibodies?. Nat Rev Immunol 10, 299–300 (2010). https://doi.org/10.1038/nri2764
Issue Date:
DOI: https://doi.org/10.1038/nri2764
- Springer Nature Limited
This article is cited by
-
Medikamentöse Prophylaxe während intensivierter Immunsuppression bei Kindern und Jugendlichen
Zeitschrift für Rheumatologie (2013)